Y-Intercept (HK)’s Clover Health Investments CLOV Stock Holding History

Y-Intercept (HK)’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,532	Closed	-$44.9K	–	1769
2026 Q1	$44.9K	Buy	+25,532	New	+$55.4K	﹤0.01%	1485
2025 Q2	–	Sell	-57,787	Closed	-$207K	–	1671
2025 Q1	$207K	Buy	57,787 +14,958	+35%	+$60.1K	0.01%	1042
2024 Q4	$135K	Buy	+42,829	New	+$153K	0.01%	1085
2024 Q2	–	Sell	-48,444	Closed	-$38.5K	–	1459
2024 Q1	$38.5K	Sell	48,444 -20,265	-29%	-$18.4K	﹤0.01%	1307
2023 Q4	$65.4K	Buy	+68,709	New	+$67.5K	0.01%	1137
2023 Q3	–	Sell	-389,053	Closed	-$349K	–	1120
2023 Q2	$349K	Buy	+389,053	New	+$345K	0.04%	709
2021 Q2	–	Sell	-75,009	Closed	-$539K	–	656
2021 Q1	$539K	Buy	+75,009	New	+$846K	0.14%	239

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Y-Intercept (HK)'s CLOV Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Clover Health Investments (CLOV) in Q2 2026, closing a stake of 25,532 shares — an estimated $44.9K sold.

Y-Intercept (HK) first reported a position in CLOV in Q1 2021 and held it in 7 quarters. The position peaked at $539K in Q1 2021. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

Y-Intercept (HK) reported no remaining Clover Health Investments position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 25,532 Clover Health Investments shares in Q2 2026, an estimated $44.9K.
Y-Intercept (HK) first reported a position in Clover Health Investments in Q1 2021 and held it in 7 quarters.
Y-Intercept (HK)'s Clover Health Investments position peaked at $539K in Q1 2021.
226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.